Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bujanda

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Human Genetics|November 13, 2013
A genome-wide association study on copy-number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancerC Fernandez-Rozadilla, J B Cazier, I Tomlinson, et al.
Endoscopy|March 23, 2012
Clinical practice guidelines: quality of colonoscopy in colorectal cancer screeningR Jover, M Herráiz, O Alarcón, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 17, 2017
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progressionO Erice, I Labiano, A Arbelaiz, et al.
Gut|June 26, 2010
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapyC Loras, J P Gisbert, M Mínguez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2021
Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registryA Hernández-Camba, L Arranz, I Vera, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2019
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registryM Iborra, B Beltrán, A Fernández-Clotet, et al.
British Journal of Cancer|August 4, 2011
A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22A Abulí, C Fernández-Rozadilla, M D Giráldez, et al.
The American Journal of Gastroenterology|August 13, 2019
Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome After (Sub)total Colectomy: Results of a 5-Year International Prospective Cohort StudyA G C Bleijenberg, J E G IJspeert, S Carballal, et al.
The American Journal of Gastroenterology|May 24, 2017
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida RegistryMaría Chaparro, M Ramas, J M Benítez, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2011
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patientsY González-Lama, F Bermejo, A López-Sanromán, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Human Genetics|November 13, 2013
A genome-wide association study on copy-number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancerC Fernandez-Rozadilla, J B Cazier, I Tomlinson, et al.
Endoscopy|March 23, 2012
Clinical practice guidelines: quality of colonoscopy in colorectal cancer screeningR Jover, M Herráiz, O Alarcón, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 17, 2017
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progressionO Erice, I Labiano, A Arbelaiz, et al.
Gut|June 26, 2010
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapyC Loras, J P Gisbert, M Mínguez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2021
Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registryA Hernández-Camba, L Arranz, I Vera, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2019
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registryM Iborra, B Beltrán, A Fernández-Clotet, et al.
British Journal of Cancer|August 4, 2011
A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22A Abulí, C Fernández-Rozadilla, M D Giráldez, et al.
The American Journal of Gastroenterology|August 13, 2019
Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome After (Sub)total Colectomy: Results of a 5-Year International Prospective Cohort StudyA G C Bleijenberg, J E G IJspeert, S Carballal, et al.
The American Journal of Gastroenterology|May 24, 2017
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida RegistryMaría Chaparro, M Ramas, J M Benítez, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2011
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patientsY González-Lama, F Bermejo, A López-Sanromán, et al.
Pageof 11